Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell
• Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
Here's a roundup of top developments in the biotech space over the last 24 hours:
RVL Pharma Issues Interim Q2 Sales From Its Droopy Eye Treatment
RVL Pharmaceuticals plc (NASDAQ:RVLP) announced preliminary Q2 FY22 sales from Upneeq of $8.4 million, up 42% sequentially. Upneeq (oxymetazoline hydrochloride…
RVL Pharmaceuticals plc – Ordinary Shares’s Return On Capital Employed Insights
Benzinga Pro data, RVL Pharmaceuticals plc - Ordinary Shares (NASDAQ:RVLP) reported Q4 sales of $2.86 million. Earnings fell to a loss of $19.72 million, resulting in a 10.43% decrease from last quarter.
RVL Pharmaceuticals plc – Ordinary Shares’s Earnings: A Preview
RVL Pharmaceuticals plc - Ordinary Shares (NASDAQ:RVLP) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement.
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
Osmotica Pharma Announces Rebranding As RVL Pharma, Issues Q4 Sales Outlook
Osmotica Pharmaceuticals plc (NASDAQ: OSMT) will change its name to RVL Pharmaceuticals plc and start trading under the new ticker (NASDAQ: RVLP).
Osmotica Pharmaceuticals Announces Corporate Name Change to RVL Pharmaceuticals plc With New Ticker Symbol ‘RVLP’
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) ("OSMT" or the "Company"), a specialty pharmaceutical company, announced today that the Company has changed its name to RVL Pharmaceuticals plc (Nasdaq: RVLP) ("RVL").